Documento fuente o registro público

FDA 510(k) K231020 — Alinity c Tricyclic Antidepressants Reagent Kit

FDA 510(k) index record K231020. Device: Alinity c Tricyclic Antidepressants Reagent Kit. Applicant as listed: Microgenics Corporation. Decision date: 2023-11-17.

OtherU.S. Food and Drug Administration (FDA)2023-11-17

Fuente

"device_name": "Alinity c Tricyclic Antidepressants Reagent Kit"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-28

Disclaimer

professional use

FDA 510(k) public index record K231020.

Device name: Alinity c Tricyclic Antidepressants Reagent Kit. Applicant as listed: Microgenics Corporation.

Decision date: 2023-11-17. Decision wording: Substantially Equivalent.

Product code: LFH. Regulation: 21 CFR 862.3910. Medical specialty: Clinical Toxicology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más